Second-generation interferons for cancer: clinical targets

This publication has 146 references indexed in Scilit:

• A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis
  New England Journal of Medicine, 1999
• Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat
  European Journal Of Cancer, 1997
• Long-term Toxicity and Neuropathology Associated with the Sequencing of Cranial Irradiation and Enhanced Chemotherapy Delivery
  Neurosurgery, 1997
• The Treatment of Recurrent Unresectable and Malignant Meningiomas with Interferon Alpha-2B
  Neurosurgery, 1997
• Induction of apoptotic cell death in non‐melanoma skin cancer by interferon‐α
  International Journal of Cancer, 1995
• Carboplatin and α-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot study
  European Journal Of Cancer, 1994
• Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial
  European Journal of Cancer and Clinical Oncology, 1986
• Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon
  New England Journal of Medicine, 1984
• Clinical effect of interferon in malignant brain tumours
  Neurosurgical Review, 1984
• Initial Interaction of Human Fibroblast and Leukocyte Interferons with FS-4 Fibroblasts
  Journal of General Virology, 1979